From: Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France
Total
Low-dose
Intermediate-dose
High-dose
Recovery, n (%)
237 (73.8)
10 (55.5)
189 (76.2)
38 (69)
Treatment failure, n (%)
52 (16.2)
5 (27.8)
35 (14.1)
12 (21.8)
Lost to follow-up, n (%)
32 (10)
3 (16.7)
24 (9.7)
5 (9.1)